Renaissance Capital LLC Beam Therapeutics Inc. Transaction History

Renaissance Capital LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 06, 2023	BUY	$36.73 - $51.6 $852,980 - $1.2 Million	23,223 New	23,223 $0
Q2 2022 Jul 11, 2022	SELL	$29.86 - $62.36 $476,416 - $994,953	-15,955 Closed	0 $0
Q1 2022 May 12, 2022	SELL	$53.73 - $82.16 $256,560 - $392,314	-4,775 Reduced 23.03%	15,955 $914,000
Q4 2021 Feb 01, 2022	SELL	$68.02 - $99.06 $203,787 - $296,783	-2,996 Reduced 12.63%	20,730 $1.65 Million
Q3 2021 Feb 01, 2022	BUY	$84.37 - $133.6 $2 Million - $3.17 Million	23,726 New	23,726 $2.06 Million

236

75.2M

438K

232K

Ticker BEAM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,354,600
Market Cap $1.78B
Description
Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...

Get notified when there are updates to the investment portfolio of Renaissance Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Renaissance Capital LLC with notifications on news.